Pharmacokinetics and Soft-Tissue Penetration of Tebipenem (SPR994) in Healthy Volunteer Subjects and Diabetic Patients With Lower Limb Infections
Latest Information Update: 26 Oct 2023
At a glance
- Drugs Tebipenem pivoxil (Primary)
- Indications Haemophilus infections; Pyelonephritis; Streptococcal infections; Urinary tract infections
- Focus Pharmacokinetics
- 18 Oct 2023 Status changed from recruiting to completed.
- 13 Jun 2022 Results (n=6) presented at the ASM Microbe 2022
- 04 Mar 2022 Status changed from not yet recruiting to recruiting.